Belgian insurance giant Ageas has agreed to buy Esure, the UK-based owner of the Sheilas’ Wheels brand, for £1.295 billion, it said on Monday. Ageas said it had agreed a deal with Esure’s owners, investment group Bain Capital, which will create the third-largest platform in the UK for personal lines such as motor and home insurance. Hans De Cuyper, Ageas’ chief executive, said the deal comes after several years of “significant growth” in the UK market for the Belgian company. Esure has undergone a turnaround in recent years, and made a trading profit of £127 million in 2024 compared to a loss the year before, while turnover grew by one-sixth to £1.1 billion. It offers car and home insurance and has about two million customers, with Sheilas’ Wheels and First Alternative as its leading brands. The company went public in 2013, with a listing on the London Stock Exchange, before Bain bought it for £1.2 billion five years later. The deal with Ageas is the latest in a period of consolidation in the UK insurance market, after Aviva agreed to buy Direct Line last year. Ageas had also made two bids to buy Direct Line, which represented a similar opportunity to grow its exposure to the UK’s personal lines insurance sector, but ultimately abandoned the effort in 2024. The deal to buy Esure is expected to complete in the second half of this year, subject to regulatory approval. Ant Middle, Ageas’ UK boss, added: “As demand for motor and home insurance grows, Ageas will be perfectly positioned to gain market share and become the insurer of choice for our existing and new customers.” “We want to continue to grow our broker and partnerships personal lines business in the UK, and Esure will help us to rapidly expand our direct distribution, our customer reach, and our scale overall. “Esure’s technical capabilities will match Ageas UK’s and will enable us to develop our well-balanced business at greater pace and serve a wider range of customers. We’re really excited for the potential this brings our UK business and wider group.” David McMillan, Esure chief, said the companies are “two highly complementary businesses and creates an even stronger platform for continued innovation, growth and excellent delivery for our customers”. View Comments
Sheilas’ Wheels owner bought by Belgian insurer in £1.3bn deal
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...